In Vivo Femtosecond Laser Machined Transepithelial Nonlinear Optical Corneal Crosslinking Compared to Ultraviolet Corneal Crosslinking
Translational Vision Science & Technology · 2024
DOI: 10.1167/tvst.13.10.9 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Translational Vision Science & Technology, 2024. Verfasst von Samantha Bradford und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Gavin Hebert Eye Institute, University of California, Irvine, CA, USA. Hauptthemen laut MEDLINE: Cross-Linking Reagents, Riboflavin, Ultraviolet Rays, Tomography, Optical Coherence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NEI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Purpose
This study assessed the safety and efficacy of transepithelial crosslinking (CXL) using femtosecond (FS) laser-machined epithelial microchannels (MCs) followed by UVA CXL compared to FS laser (NLO CXL) in rabbits.
Methods
The epithelium of 36 rabbits was machined to create 2- by 25-µm MCs at 400 MCs/mm2. Eyes were treated with 1% riboflavin (Rf) solution for 30 minutes, rinsed, and then crosslinked using UVA or NLO CXL. Rabbits were monitored by epithelial staining, optical coherence tomography (OCT) imaging, and esthesiometry. After sacrifice at 2, 4, or 8 weeks, corneas were examined for collagen autofluorescence and immunohistochemistry.
Results
NLO CXL showed no epithelial damage compared to UVA CXL, which produced on average 23.89 ± 5.6 mm2 epithelial defects that healed by day 3. UVA CXL also produced loss of corneal sensitivity averaging 0.83 ± 0.24 cm force to elicit a blink response that persisted for 28 days and remained significantly lower than control or NLO CXL. OCT imaging detected the presence of a demarcation line only following UVA CXL but not NLO CXL.
Conclusions
Even with improved transepithelial Rf penetration, UVA CXL resulted in severe epithelial damage, loss of corneal sensitivity, and delayed wound healing persisting for a month. When MCs were paired with NLO CXL, however, these issues were mostly negated. This suggests that MC NLO CXL can achieve a faster visual recovery without postoperative pain or risk of infection. Translational Relevance: UVA CXL is a successful procedure, but there is a need for a transepithelial protocol. The combination of MCs and NLO CXL is able to keep the benefits of UVA CXL without causing epithelial damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Gavin Hebert Eye Institute, University of California, Irvine, CA, USA.
- Department of Biomedical Engineering, University of California, Irvine, CA, USA.
Förderung
- NCI NIH HHS
- NEI NIH HHS
- NIH HHS
Zitieren
APA
Bradford, S., Joshi, R., Luo, S., Farrah, E., Xie, Y., Brown, D. J., Juhasz, T., & Jester, J. V. (2024). In Vivo Femtosecond Laser Machined Transepithelial Nonlinear Optical Corneal Crosslinking Compared to Ultraviolet Corneal Crosslinking. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.13.10.9
Vancouver
Bradford S, Joshi R, Luo S, Farrah E, Xie Y, Brown DJ, et al. In Vivo Femtosecond Laser Machined Transepithelial Nonlinear Optical Corneal Crosslinking Compared to Ultraviolet Corneal Crosslinking. Translational Vision Science & Technology. 2024. doi:10.1167/tvst.13.10.9
BibTeX
@article{Bradford2024,
author = {Bradford, Samantha and Joshi, Rohan and Luo, Shangbang and Farrah, Emily and Xie, Yilu and Brown, Donald J and Juhasz, Tibor and Jester, James V},
title = {In Vivo Femtosecond Laser Machined Transepithelial Nonlinear Optical Corneal Crosslinking Compared to Ultraviolet Corneal Crosslinking},
journal = {Translational Vision Science & Technology},
year = {2024},
doi = {10.1167/tvst.13.10.9}
}
EUVIMED